v3.26.3
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Apr. 14, 2025
Balance (in Shares) at Apr. 14, 2025      
Class B ordinary shares issued to Sponsor [1] $ 843 24,157 25,000
Class B ordinary shares issued to sponsor (Shares) [1] 8,433,333      
Net income (loss) (47,545) (47,545)
Balance at Jun. 30, 2025 $ 843 24,157 (47,545) (22,545)
Balance (in Shares) at Jun. 30, 2025 8,433,333      
Balance at Apr. 14, 2025
Balance (in Shares) at Apr. 14, 2025      
Net income (loss)         342,819
Balance at Sep. 30, 2025 $ 843 (12,067,094) (12,066,251)
Balance (in Shares) at Sep. 30, 2025 8,433,333      
Balance at Jun. 30, 2025 $ 843 24,157 (47,545) (22,545)
Balance (in Shares) at Jun. 30, 2025 8,433,333      
Sale of 4,266,667 Private Placement Warrants 6,400,000 6,400,000
Fair Value of Public Warrants at issuance 3,078,167 3,078,167
Allocated value of transaction costs to Class A shares (224,266) (224,266)
Accretion for Class A ordinary shares subject to redemption amount (9,278,058) (12,409,913) (21,687,971)
Net income (loss) 390,364 390,364
Balance at Sep. 30, 2025 $ 843 (12,067,094) (12,066,251)
Balance (in Shares) at Sep. 30, 2025 8,433,333      
Balance at Dec. 31, 2025 $ 843 (12,788,691) (12,787,848)
Balance (in Shares) at Dec. 31, 2025 8,433,333      
Accretion for Class A ordinary shares subject to redemption amount (2,103,365) (2,103,365)
Net income (loss) 1,724,603 1,724,603
Balance at Mar. 31, 2026 $ 843 (13,167,453) (13,166,610)
Balance (in Shares) at Mar. 31, 2026 8,433,333      
Balance at Dec. 31, 2025 $ 843 (12,788,691) (12,787,848)
Balance (in Shares) at Dec. 31, 2025 8,433,333      
Net income (loss)         3,770,456
Balance at Jun. 30, 2026 $ 843 (13,519,584) [2] (13,518,741)
Balance (in Shares) at Jun. 30, 2026 8,433,333      
Balance at Dec. 31, 2025 $ 843 (12,788,691) (12,787,848)
Balance (in Shares) at Dec. 31, 2025 8,433,333      
Net income (loss)         6,060,495
Balance at Sep. 30, 2026 $ 843 (13,696,698) (13,695,855)
Balance (in Shares) at Sep. 30, 2026 8,433,333      
Balance at Mar. 31, 2026 $ 843 (13,167,453) (13,166,610)
Balance (in Shares) at Mar. 31, 2026 8,433,333      
Accretion for Class A ordinary shares subject to redemption amount (2,397,984) [2] (2,397,984)
Net income (loss) 2,045,853 [2] 2,045,853
Balance at Jun. 30, 2026 $ 843 (13,519,584) [2] (13,518,741)
Balance (in Shares) at Jun. 30, 2026 8,433,333      
Accretion for Class A ordinary shares subject to redemption amount (2,467,153) (2,467,153)
Net income (loss) 2,290,039 2,290,039
Balance at Sep. 30, 2026 $ 843 $ (13,696,698) $ (13,695,855)
Balance (in Shares) at Sep. 30, 2026 8,433,333      
[1] Includes an aggregate of up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised by the underwriters in full (Note 5). On August 4, 2025, the underwriters exercised their over-allotment option and as of such date, 1,100,000 founder shares were no longer subject to forfeiture.
[2] The net income for the three months ended June 30, 2026 and the accumulated deficit and total shareholders’ deficit balances as of June 30, 2026 have been revised to correct an over-accrual of legal expenses. See Note 2 — Revision of Previously Issued Financial Statements.